This inventor holds 3 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Xenoport, Inc., Lonza Inc.. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Uwe Zacher: Innovator in Pharmaceutical Chemistry
Introduction
Uwe Zacher is a notable inventor based in Brig, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on innovative processes and compounds that have potential applications in medicine.
Latest Patents
Among his latest patents is a crystalline form of γ-aminobutyric acid analog. This invention provides a method for preparing this crystalline form, which may have various therapeutic uses. Another significant patent is for the process of producing L-carnitine tartrate. This process involves precipitating L-carnitine tartrate from a reaction mixture containing L-carnitine and tartaric acid dissolved in ethanol, with specific water content requirements.
Career Highlights
Uwe Zacher has worked with prominent companies in the pharmaceutical industry, including Xenoport, Inc. and Lonza Inc. His experience in these organizations has contributed to his expertise in developing innovative chemical processes and compounds.
Collaborations
Some of his notable coworkers include Tono Estrada and Stephen P Raillard. Their collaboration has likely fostered a productive environment for innovation and research.
Conclusion
Uwe Zacher's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile